News stories about Syneron Medical (NASDAQ:ELOS) have been trending somewhat positive this week, Accern reports. Accern scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Syneron Medical earned a news impact score of 0.18 on Accern’s scale. Accern also gave media headlines about the medical equipment provider an impact score of 46.1414429437326 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Syneron Medical (NASDAQ:ELOS) remained flat at $$11.00 during trading hours on Friday. 3,905 shares of the company were exchanged, compared to its average volume of 562,777. Syneron Medical has a 52 week low of $6.18 and a 52 week high of $11.43.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2017/11/11/syneron-medical-elos-earns-daily-news-sentiment-score-of-0-18.html.
Syneron Medical Company Profile
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.
Receive News & Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.